QSML - ETF AI Analysis
Top Page
WisdomTree U.S. SmallCap Quality Growth Fund (QSML)
Rating:69Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has delivered strong gains so far this year and over the past few months, showing solid recent momentum.
Broad Sector Diversification
Holdings are spread across many sectors, including technology, consumer, financials, industrials, and health care, which helps reduce the impact if one area of the market struggles.
Several Strong-Performing Top Holdings
Some of the largest positions, such as TG Therapeutics, Sezzle, Victory Capital, and Ligand Pharma, have shown strong gains, supporting the fund’s overall results.
Negative Factors
Higher Expense Ratio for a Passive ETF
The fund’s expense ratio is on the higher side for an ETF, which means more of your returns go toward fees each year.
Small Asset Base
The ETF manages a relatively small amount of money, which can sometimes lead to higher trading spreads and a greater risk the fund could be closed if it does not grow.
Heavy U.S. and Small-Cap Focus
With almost all exposure in U.S. small-cap stocks, the fund is sensitive to swings in this part of the market and offers little geographic diversification.
QSML vs. SPDR S&P 500 ETF (SPY)
AUM12.27M
RegionNorth America
Expense Ratio0.38%
Beta1.05
IssuerWisdomTree
Inception DateJan 25, 2024
Dividend Yield0.53%
Asset ClassEquity
Index TrackedWisdomTree US SmallCap Quality Growth Index - Benchmark TR Gross
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume470
30 Day Avg. Volume651
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
39.58Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering377
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
QSML Summary
The WisdomTree U.S. SmallCap Quality Growth Fund (QSML) is an ETF that tracks the WisdomTree US SmallCap Quality Growth Index, focusing on smaller U.S. companies with strong business performance and growth potential. It holds a mix of sectors like technology, consumer, financials, and health care, with names such as Hims & Hers Health and Essent Group. An investor might choose QSML to seek long-term growth and add diversification beyond large, well-known stocks. However, because it invests in small companies and growth-focused stocks, its price can be more volatile and may rise or fall quickly with market conditions.
How much will it cost me?The ETF QSML has an expense ratio of 0.38%, which means you’ll pay $3.80 per year for every $1,000 invested. This is slightly higher than average because it is actively managed to focus on small-cap companies with strong growth and quality fundamentals.
What would affect this ETF?The QSML ETF, which focuses on U.S. small-cap companies with strong growth potential, could benefit from economic expansion and innovation in sectors like technology and consumer cyclical, which are key areas of exposure. However, it may face challenges from rising interest rates or economic slowdowns, which can negatively impact small-cap stocks and growth-oriented investments. Additionally, sector-specific risks, such as regulatory changes in energy or healthcare, could influence performance.
QSML Top 10 Holdings
QSML leans into U.S. small-cap growth, with a noticeable tilt toward health care and financial names that are doing much of the heavy lifting. TG Therapeutics and Ligand Pharma have been rising, giving the fund a biotech-style boost, while Victory Capital and ACI Worldwide add steady, finance-and-tech-driven momentum. On the flip side, Installed Building Products and Acushnet Holdings have been lagging, acting like a bit of sand in the gears. Overall, the ETF is U.S.-focused, spread across sectors but with clear exposure to small, fast-growing innovators.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Victory Capital Holdings | 0.63% | $76.27K | $6.19B | 50.54% | 80 Outperform | |
| Essent Group | 0.63% | $75.94K | $6.08B | 17.21% | 73 Outperform | |
| TG Therapeutics | 0.62% | $74.56K | $7.96B | 60.76% | 65 Neutral | |
| Marketaxess Holdings | 0.61% | $73.68K | $5.71B | -22.51% | 68 Neutral | |
| Lyft | 0.61% | $73.01K | $6.02B | 16.34% | 69 Neutral | |
| Enova International | 0.61% | $72.92K | $6.33B | 152.02% | 71 Outperform | |
| Installed Building Products | 0.61% | $72.88K | $6.01B | 7.25% | 74 Outperform | |
| Hims & Hers Health | 0.59% | $71.16K | $6.43B | -51.35% | 68 Neutral | |
| Epam Systems | 0.59% | $70.47K | $5.51B | -30.03% | 70 Neutral | |
| Acushnet Holdings | 0.58% | $69.39K | $5.93B | 27.69% | 74 Outperform |
QSML Technical Analysis
Positive
―
Price Trends
32.72
Positive
31.09
Positive
30.01
Positive
Market Momentum
0.51
Negative
68.59
Neutral
98.70
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For QSML, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 33.72, equal to the 50-day MA of 32.72, and equal to the 200-day MA of 30.01, indicating a bullish trend. The MACD of 0.51 indicates Negative momentum. The RSI at 68.59 is Neutral, neither overbought nor oversold. The STOCH value of 98.70 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for QSML.
QSML Peer Comparison
Comparison Results
Performance Comparison
QSML
WisdomTree U.S. SmallCap Quality Growth Fund
34.99
8.54
32.29%
TMFS
Motley Fool Small-Cap Growth ETF
―
―
―
MMSC
First Trust Multi-Manager Small Cap Opportunities ETF
―
―
―
CAFG
Pacer US Small Cap Cash Cows Growth Leaders ETF
―
―
―
SGRW
Harbor Active Small Cap Growth ETF
―
―
―
ACSG
American Century Small Cap Growth Insights ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents